Syros Pharmaceuticals【SYRS】株式ニュース

名称	銘柄コード	市場	種別
Syros Pharmaceuticals Inc	SYRS	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	-0.37	-6.48%	5.34	13:00:01

始値	安値	高値	終値	前日終値
5.61	5.24	5.61	5.34	5.71

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/6/13	20:00	BW	Syros to Host Webcast Event on Higher-Risk Myelodysplastic..
2024/6/08	05:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/07	05:30	EDGAR2	Form 8-K - Current report
2024/5/14	20:30	BW	Syros Reports First Quarter 2024 Financial Results and..
2024/5/14	19:42	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/07	22:00	BW	Syros to Participate in Upcoming Investor Conferences
2024/5/07	20:00	BW	Syros to Report First Quarter 2024 Financial Results on..
2024/4/09	20:00	BW	Syros Receives Fast Track Designation from the FDA for..
2024/4/03	05:30	BW	Syros Reports Inducement Grants Under Nasdaq Listing Rule..
2024/3/27	20:30	BW	Syros Reports Fourth Quarter and Full Year 2023 Financial..
2024/3/27	19:57	IHMARKETNEWS	U.S. Stock Index Futures Point to a Rebound, Oil See..
2024/3/25	20:00	BW	Syros Announces Completion of Enrollment of 190 Patients..
2024/3/20	20:00	BW	Syros to Report Fourth Quarter and Full Year 2023 Financial..
2024/2/27	21:00	BW	Syros to Participate in TD Cowen 44th Annual Health Care..
2024/2/15	10:56	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2024/2/14	10:22	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/14	09:02	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/14	08:59	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/08	21:06	EDGAR2	Form 8-K - Current report
2024/1/08	21:00	BW	Syros Highlights Anticipated 2024 Milestones to Deliver on..
2024/1/03	06:15	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2023/12/27	07:19	EDGAR2	Form SC 13D/A - General statement of acquisition of..
2023/12/20	06:59	EDGAR2	Form 8-K - Current report
2023/12/20	06:53	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/12/19	21:27	BW	Syros Announces Pricing of $45.0 million Underwritten..
2023/12/15	06:24	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/13	06:12	EDGAR2	Form 144 - Report of proposed sale of securities
2023/12/09	06:23	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/07	06:00	EDGAR2	Form 144 - Report of proposed sale of securities
2023/12/06	21:05	EDGAR2	Form 8-K - Current report
2023/12/06	21:00	BW	Syros Announces Encouraging Initial Data from Randomized..
2023/12/06	07:28	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/11/21	21:30	BW	Syros to Participate in Upcoming Investor Conferences
2023/11/14	21:30	BW	Syros Reports Third Quarter 2023 Financial Results and..
2023/11/14	20:47	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/07	21:30	BW	Syros to Report Third Quarter 2023 Financial Results on..
2023/11/03	05:53	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/11/03	05:52	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/11/03	05:52	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/11/03	05:51	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/10/21	05:15	EDGAR2	Form SC 13D - General statement of acquisition of beneficial..
2023/10/02	21:49	EDGAR2	Form 8-K - Current report
2023/10/02	21:45	BW	Syros Announces Planned CEO Leadership Transition and..
2023/9/08	05:30	BW	Syros Reports Inducement Grants Under Nasdaq Listing Rule..
2023/8/12	05:30	EDGAR2	Form 8-K - Current report
2023/8/08	20:30	BW	Syros Reports Second Quarter 2023 Financial Results and..
2023/8/08	19:53	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/05	05:30	BW	Syros Reports Inducement Grants Under Nasdaq Listing Rule..
2023/8/03	05:21	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/8/01	20:30	BW	Syros to Report Second Quarter 2023 Financial Results on..